In a cohort of patients with advanced NSCLC, Li et al.[22] reported a higher ORR to immunotherapy in current and former smokers than never smokers (36% vs. 26% vs. 14%, P = 0.02) even when controlling for PD-L1 expression levels. Here, CD274 is linked to non-small cell lung carcinoma.